The study confirmed no abnormal dangers, which indicated that it could be safely administered in a clinical research context. Later on, Dr. Charles Grob requested permission to more review the material with cancer individuals, but was denied from the FDA twice.One particular reliable source operating in a legal natural environment could be the Shro